Research Projects & Grants

Internal

• Phase I-II trial of stereotactic body proton therapy for patients with liver metastases, Role: PI, LLU Dept. of Radiation Medicine, (08/2024 - 08/2025) Status: Approved
• A phase II trial of proton chemotherapy (PCT) for resectable esophageal or esophagogastric junction cancer, Role: PI, LLU Dept. of Radiation Medicine, (08/2024 - 08/2025) Status: Approved
• Phase I-II trial of hypofractionated conformal proton beam radiation therapy for favorable-risk prostate cancer, Role: Investigator, LLU Dept. of Radiation Medicine, (01/2025 - 01/2026) Status: Approved
• Radiation medicine research registry, Role: Investigator, LLU Dept. of Radiation Medicine, (10/2024 - 09/2025) Status: Approved
• Investigator Initiated: A phase II trial of preoperative chemotherapy (with gemcitabine and nab-paclitaxel) and stereotactic body radiotherapy followed by surgery and chemotherapy in patients with resectable pancreatic adenocarcinoma, Role: Investigator, LLU Dept. of Surgery, (09/2024 - 09/2025) Status: Approved
• A phase II study of preoperative proton therapy in soft tissue sarcomas of the extremities and body wall, Role: PI, LLU Dept. of Radiation Medicine, (05/2022 - 05/2023) Status: Completed
• In-Field Local Control of Liver Metastases after Proton Therapy, Role: PI, LLU Dept. of Radiation Medicine, (10/2020) Status: Approved

Non-Profit Organization

• A prospective comparative study of outcomes with proton and photon radiation in prostate cancer (COMPPARE), Role: Investigator, Patient-Centered Outcomes Research Institute (PCORI), (08/2024 - 08/2025) Status: Approved